Trading Nontradables — expanded estimators

Muñoz (2024), QJE. https://doi.org/10.1093/qje/qjad032

3 specifications. Effects are in outcome standard deviations; intervals are 95%.

Treatment adoption

Treatment adoption timing

S17-P001: seeded sample of 69 of 69 eligible units. Purple untreated; yellow treated; white unobserved.

TN-F2-ANNOTATED-SCALAR

TN-F2-ANNOTATED-SCALAR · S17-P001 · Data & fit details

814 observations · 69 units · 69 clusters · 23 treated / 46 control units.

Estimate comparison

S17-P001: point estimates, targets and available 95% intervals
Estimator Estimate (SDs) SE 95% CI Averaging
Static TWFE 0.584 0.155 [0.274, 0.893] Coefficient
Dynamic TWFE 0.783 0.126 [0.532, 1.034] Treated cells
BJS / did2s 0.741 0.141 [0.459, 1.023] Treated cells
Sun–Abraham 0.757 0.120 [0.518, 0.996] Treated cells
CS-DID (equal event-time) 1.096 0.172 [0.758, 1.434] Equal post-event times
CS-DID (treated cells) 0.973 0.136 [0.707, 1.239] Treated cells
Matrix completion 0.804 — — Treated cells

Event studies

Periods −10 to +10; pointwise 95% intervals where available.

Dynamic TWFE event study BJS / did2s event study Sun–Abraham event study CS-DID event study Matrix completion event study

TN-F2-BASELINE

TN-F2-BASELINE · S17-P002 · Data & fit details

913 observations · 71 units · 71 clusters · 23 treated / 48 control units.

Estimate comparison

S17-P002: point estimates, targets and available 95% intervals
Estimator Estimate (SDs) SE 95% CI Averaging
Static TWFE 0.543 0.144 [0.256, 0.830] Coefficient
Dynamic TWFE 0.789 0.119 [0.551, 1.026] equal_periods
BJS / did2s 0.705 0.142 [0.422, 0.987] equal_periods
Sun–Abraham 0.797 0.110 [0.577, 1.016] equal_periods
CS-DID (equal event-time) 0.978 0.158 [0.669, 1.286] Equal post-event times
CS-DID (treated cells) 0.893 0.122 [0.654, 1.132] Treated cells
Matrix completion 0.736 — — Treated cells

Event studies

Periods −10 to +10; pointwise 95% intervals where available.

Dynamic TWFE event study BJS / did2s event study Sun–Abraham event study CS-DID event study Matrix completion event study

TN-F2-ORIGINDESTYEAR

TN-F2-ORIGINDESTYEAR · S17-P003 · Data & fit details

No common absorbing-treatment sample with observed −1 and untreated counterfactual support.